Literature DB >> 137852

[Salivary gland scintigraphy after radio-iodine therapy. Functional scintigraphy of the salivary gland after high dose radio-iodine therapy (author's transl)].

H H Albrecht, H Creutzig.   

Abstract

Following high dose radio-iodine therapy, some radiation damage to the salivary glands is to be expected since iodine is taken up by these glands. The great individual variation in the uptake makes it impossible to predict the severity of the damage. T max and maximal excretion capacity after stimulation were therefore estimated by a camera functional scintigram with digital read out in patients following radioiodine therapy (0.1-3.2 Ci); the excretion index was used as an indirect measure of salivary flow. After a dose up to 0.3 Ci there is a change of T max and maximal excretion capacity in 30% of patients; after a dose of 0.5 to 1 Ci it is found in 60 and 80% and after very high doses of 1.1 to 3.2 Ci an abnormal Tmax was found in two-thirds of all patients and reduced or absent excretion capacity in all nine patients in this group. The excretion index also depended significantly on the cumulative dose. All patients who had received very high doses showed marked hyposialia or asialia. The early results of interim examinations suggest, similar to radio-iodine induced hypothyroidism, a cumulative risk of reduced function. In view of the long survival period of patients with differentiated thyroid carcinomas attention should be drawn to this side effect.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 137852     DOI: 10.1055/s-0029-1230516

Source DB:  PubMed          Journal:  Rofo        ISSN: 1438-9010


  7 in total

1.  A computer-assisted method for semi-quantitative assessment of salivary gland diseases.

Authors:  G De Rossi; C Focacci
Journal:  Eur J Nucl Med       Date:  1980-12

Review 2.  Does amifostine have radioprotective effects on salivary glands in high-dose radioactive iodine-treated differentiated thyroid cancer.

Authors:  Chao Ma; Jiawei Xie; Zhongxin Jiang; Guoming Wang; Shuyao Zuo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-02-04       Impact factor: 9.236

3.  Salivary gland protection by amifostine in high-dose radioiodine therapy of differentiated thyroid cancer.

Authors:  K H Bohuslavizki; S Klutmann; C Bleckmann; W Brenner; S Lassmann; J Mester; E Henze; M Clausen
Journal:  Strahlenther Onkol       Date:  1999-02       Impact factor: 3.621

4.  Early immunohistochemical and functional markers indicating radiation damage of the parotid gland.

Authors:  S G Hakim; H Ch Jacobsen; D Hermes; H Kosmehl; I Lauer; R Nadrowitz; P Sieg
Journal:  Clin Oral Investig       Date:  2004-01-21       Impact factor: 3.573

5.  Morphometric and functional changes of salivary gland dysfunction after radioactive iodine ablation in a murine model.

Authors:  Jeong-Seok Choi; In Suh Park; Seok-Ki Kim; Jae-Yol Lim; Young-Mo Kim
Journal:  Thyroid       Date:  2013-07-25       Impact factor: 6.568

Review 6.  RETRACTED ARTICLE: Radiation sialadenitis induced by high-dose radioactive iodine therapy.

Authors:  Shin Young Jeong; Jaetae Lee
Journal:  Nucl Med Mol Imaging       Date:  2010-04-21

Review 7.  Strategies for Radioiodine Treatment: What's New.

Authors:  Clotilde Sparano; Sophie Moog; Julien Hadoux; Corinne Dupuy; Abir Al Ghuzlan; Ingrid Breuskin; Joanne Guerlain; Dana Hartl; Eric Baudin; Livia Lamartina
Journal:  Cancers (Basel)       Date:  2022-08-04       Impact factor: 6.575

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.